FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

418771004: Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    2574707013 Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT core module
    2578104016 Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial en Synonym Active Only initial character case insensitive SNOMED CT core module
    2580414010 Amphotericin (colloidal dispersion) 5mg/mL suspension for injection 20mL vial en Synonym Active Only initial character case insensitive SNOMED CT core module
    2580415011 Amphotericin (lipid complex) 5mg/mL suspension for injection 20mL vial en Synonym Active Only initial character case insensitive SNOMED CT core module
    2580416012 Amphotericin (liposomal) 5mg/mL suspension for injection 20mL vial en Synonym Active Only initial character case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial Is a Product containing amphotericin B liposome false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial Has active ingredient Amphotericin B liposome false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial Is a Product containing amphotericin in parenteral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial Has manufactured dose form Conventional release suspension for injection false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial Is a Product containing amphotericin B liposome in parenteral dosage form false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start